Cargando…
Seroprevalence of SARS-CoV-2: Insights into the epidemiology of the pandemic
AIM: This study aimed to assess the seroprevalence of SARS-CoV-2 and disease symptoms in Malakand, Pakistan. MATERIALS & METHOD: 623 samples with suspected SARS-CoV-2 were collected from different regions of Malakand and analyzed to detect SARS-CoV-2 IgG antibodies using ELISA. RESULTS: 306 (49....
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10234367/ https://www.ncbi.nlm.nih.gov/pubmed/37300952 http://dx.doi.org/10.1016/j.jiph.2023.05.036 |
_version_ | 1785052476774285312 |
---|---|
author | Ali, Amjad Waqar, Muhammad Akram, Ayesha Rafique, Shazia Rehman, Gauhar Idrees, Muhammad Halim, Sobia Ahsan Waqas, Muhammad Uddin, Jalal Gojayev, Anar Khan, Ajmal Al-Harrasi, Ahmed |
author_facet | Ali, Amjad Waqar, Muhammad Akram, Ayesha Rafique, Shazia Rehman, Gauhar Idrees, Muhammad Halim, Sobia Ahsan Waqas, Muhammad Uddin, Jalal Gojayev, Anar Khan, Ajmal Al-Harrasi, Ahmed |
author_sort | Ali, Amjad |
collection | PubMed |
description | AIM: This study aimed to assess the seroprevalence of SARS-CoV-2 and disease symptoms in Malakand, Pakistan. MATERIALS & METHOD: 623 samples with suspected SARS-CoV-2 were collected from different regions of Malakand and analyzed to detect SARS-CoV-2 IgG antibodies using ELISA. RESULTS: 306 (49.1%) 0 f 623 patients were anti-SARS-CoV-2 IgG reactive, with a higher prevalence in males (75%) than females (25%). In this study, we enrolled two groups, subjects working in a non-medical setting and subjects working in a medical setting. Clinical symptoms were statistically linked with SARS-CoV-2. Four weeks of follow-up analysis of IgG titers in health care workers showed an increase in IgG antibodies titer. CONCLUSION: This study gives insights into the community-based spread of SARS-CoV-2 infection, associated immunity, and herd immunity in the studied population. This study can provide insights to the government about early vaccination of this population as most of the population is not yet vaccinated. |
format | Online Article Text |
id | pubmed-10234367 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. |
record_format | MEDLINE/PubMed |
spelling | pubmed-102343672023-06-01 Seroprevalence of SARS-CoV-2: Insights into the epidemiology of the pandemic Ali, Amjad Waqar, Muhammad Akram, Ayesha Rafique, Shazia Rehman, Gauhar Idrees, Muhammad Halim, Sobia Ahsan Waqas, Muhammad Uddin, Jalal Gojayev, Anar Khan, Ajmal Al-Harrasi, Ahmed J Infect Public Health Article AIM: This study aimed to assess the seroprevalence of SARS-CoV-2 and disease symptoms in Malakand, Pakistan. MATERIALS & METHOD: 623 samples with suspected SARS-CoV-2 were collected from different regions of Malakand and analyzed to detect SARS-CoV-2 IgG antibodies using ELISA. RESULTS: 306 (49.1%) 0 f 623 patients were anti-SARS-CoV-2 IgG reactive, with a higher prevalence in males (75%) than females (25%). In this study, we enrolled two groups, subjects working in a non-medical setting and subjects working in a medical setting. Clinical symptoms were statistically linked with SARS-CoV-2. Four weeks of follow-up analysis of IgG titers in health care workers showed an increase in IgG antibodies titer. CONCLUSION: This study gives insights into the community-based spread of SARS-CoV-2 infection, associated immunity, and herd immunity in the studied population. This study can provide insights to the government about early vaccination of this population as most of the population is not yet vaccinated. The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. 2023-08 2023-06-01 /pmc/articles/PMC10234367/ /pubmed/37300952 http://dx.doi.org/10.1016/j.jiph.2023.05.036 Text en © 2023 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Ali, Amjad Waqar, Muhammad Akram, Ayesha Rafique, Shazia Rehman, Gauhar Idrees, Muhammad Halim, Sobia Ahsan Waqas, Muhammad Uddin, Jalal Gojayev, Anar Khan, Ajmal Al-Harrasi, Ahmed Seroprevalence of SARS-CoV-2: Insights into the epidemiology of the pandemic |
title | Seroprevalence of SARS-CoV-2: Insights into the epidemiology of the pandemic |
title_full | Seroprevalence of SARS-CoV-2: Insights into the epidemiology of the pandemic |
title_fullStr | Seroprevalence of SARS-CoV-2: Insights into the epidemiology of the pandemic |
title_full_unstemmed | Seroprevalence of SARS-CoV-2: Insights into the epidemiology of the pandemic |
title_short | Seroprevalence of SARS-CoV-2: Insights into the epidemiology of the pandemic |
title_sort | seroprevalence of sars-cov-2: insights into the epidemiology of the pandemic |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10234367/ https://www.ncbi.nlm.nih.gov/pubmed/37300952 http://dx.doi.org/10.1016/j.jiph.2023.05.036 |
work_keys_str_mv | AT aliamjad seroprevalenceofsarscov2insightsintotheepidemiologyofthepandemic AT waqarmuhammad seroprevalenceofsarscov2insightsintotheepidemiologyofthepandemic AT akramayesha seroprevalenceofsarscov2insightsintotheepidemiologyofthepandemic AT rafiqueshazia seroprevalenceofsarscov2insightsintotheepidemiologyofthepandemic AT rehmangauhar seroprevalenceofsarscov2insightsintotheepidemiologyofthepandemic AT idreesmuhammad seroprevalenceofsarscov2insightsintotheepidemiologyofthepandemic AT halimsobiaahsan seroprevalenceofsarscov2insightsintotheepidemiologyofthepandemic AT waqasmuhammad seroprevalenceofsarscov2insightsintotheepidemiologyofthepandemic AT uddinjalal seroprevalenceofsarscov2insightsintotheepidemiologyofthepandemic AT gojayevanar seroprevalenceofsarscov2insightsintotheepidemiologyofthepandemic AT khanajmal seroprevalenceofsarscov2insightsintotheepidemiologyofthepandemic AT alharrasiahmed seroprevalenceofsarscov2insightsintotheepidemiologyofthepandemic |